http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2260323-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36e8050eec40967e1cbc39ff89f2607d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46 |
| filingDate | 1992-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e1fa4e58aac4a13e209f43b3f819a88 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95e566f7b8c8c93e1c9e475528c7fe18 |
| publicationDate | 1993-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | GB-2260323-A |
| titleOfInvention | 4-piperidinyl diphenylacetates |
| abstract | Compounds of formula (I) in which R1 and R2 are each separately selected from a phenyl group which is unsubstituted or substituted by one or more groups selected from alkyl, alkoxy, alkylenedioxy, halogeno, halogeno substituted alkyl, hydroxy and nitro, R3 and R4 are each hydrogen or together are an oxo group and R5 is an alicyclic hydrocarbyl group containing from 3 to 9 carbon atoms in the ring, the compound optionally being in the form of a physiologically acceptable acid addition or quaternary ammonium salt, are of value as selective antagonists of the M3 muscarinic receptor. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0999205-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9519164-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0999205-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9932443-A1 |
| priorityDate | 1991-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 69.